跳至主要内容
临床试验/NCT01547364
NCT01547364已完成2 期

Blinded Analgesic Effect and 1 Year Outcome of Caudal D5W Injection in All-Comers With Chronic Low Back Pain and Either Buttock or Leg Pain

Smigel, Liza, M.D.1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2012年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
35
试验地点
1
主要终点
Change from Baseline to 20 minutes in Numerical Rating Scale(NRS) for Pain

研究概览

简要总结

Objective: The purposes of the study are to

  1. Explore the immediate and short term (to 48 hour) analgesic potential of epidural D5W in comparison to normal saline.
  2. Determine if cumulative benefit results from caudal dextrose injection.
  3. Evaluate accuracy of a small needle vertical approach caudal injection that will allow for blind injection of D5W.

详细描述

Injection of dextrose into the epidural space as an admixture with various steroids and anesthetic has been utilized for years for purposes of altering the specific gravity of the injectate. No safety issues or concerns have been raised about the dextrose component inclusion but a separate therapeutic effect of dextrose has not heretofore been considered. Recently dextrose has been found to treat neurogenic inflammation (pain from upregulation of the TRPV1 receptor on peptidergic nerves). An analgesic effect of dextrose on chronic pain in the presence of painful sensory nerves has been observed with injection of D5W without anesthetic. That effect begins within seconds clinically. Physicians have empirically trialed D5W for epidural injection in a 10 ml volume and found that marked or complete analgesia of chronic low back and leg pain results in the majority of patients within 15 minutes. An empirical consecutive patient date collection has demonstrated that this initial effect lasts for 2 to 48 hours, and that the effect begins to sustain after 2-3 sessions. For this reason, the current study is designed with the the first two objectives:

  1. Explore the immediate and short term (to 48 hour) analgesic potential of epidural D5W in comparison to normal saline.
  2. Determine if cumulative benefit results from caudal dextrose injection.

In addition to determining potential benefit from caudal epidural of dextrose, the accuracy of a simple vertical approach to injection of dextrose is to be evaluated. If this vertical approach is accurate it will allow for

  1. More comfort with injection.
  2. Less need for radiographic exposure, in that needle placement is quicker and easier, allowing for less fluoroscopy time.
  3. Potential for blind injection of solutions that do not include anesthetic or particulate matter, increasing potential applicability of caudal dextrose injection to situations in which fluoroscopy is not available.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • More than 3 months of back pain
  • Some pain below the iliac crest (Either in buttock or in leg)
  • At least one conservative (non-injection) modality of treatment to include physical therapy, chiropractic/osteopathic manipulation, exercises, drug therapy, and relative rest.
  • Opiate use absent or controlled
  • Psychiatric history absent or controlled
  • Current medical stability
  • Absent steroid use history or no allergy or intolerance to steroid use

排除标准

  • Unstable neurologic function

研究组 & 干预措施

Caudal Saline

Placebo Comparator

干预措施: Saline (Drug)

Caudal Dextrose

Active Comparator

干预措施: Dextrose (Drug)

结局指标

主要结局

Change from Baseline to 20 minutes in Numerical Rating Scale(NRS) for Pain

时间窗: 20 minutes

Caudal epidural injection of D5W will result in more analgesia at 20 minutes than epidural injection of normal saline.

次要结局

  • Change from Baseline to 1 year in NRS for Pain(1 year)
  • Percentage Success of Epidurogram Pattern Production with a Blind Needle Placement Using a Vertical Caudal Epidural Method(Dye instillation immediately after needle placement with observation of dye pattern fluoroscopically.)

研究者

发起方
Smigel, Liza, M.D.
申办方类型
Indiv
责任方
Principal Investigator
主要研究者

Liza Smigel, M.D.

Liza Smigel, M.D.

Smigel, Liza, M.D.

研究点 (1)

Loading locations...

相似试验